Compare FBRT & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FBRT | BLFS |
|---|---|---|
| Founded | 2012 | 1987 |
| Country | United States | United States |
| Employees | 223 | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 701.9M | 923.5M |
| IPO Year | N/A | 2013 |
| Metric | FBRT | BLFS |
|---|---|---|
| Price | $9.05 | $21.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $11.50 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 587.9K | 326.0K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 15.83% | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $96,214,000.00 |
| Revenue This Year | $12.34 | $19.73 |
| Revenue Next Year | $4.95 | $17.82 |
| P/E Ratio | $13.56 | ★ N/A |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $8.24 | $17.86 |
| 52 Week High | $11.84 | $29.57 |
| Indicator | FBRT | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 52.58 | 56.20 |
| Support Level | $8.91 | $21.35 |
| Resistance Level | $9.26 | $26.14 |
| Average True Range (ATR) | 0.20 | 1.03 |
| MACD | 0.00 | 0.10 |
| Stochastic Oscillator | 29.66 | 68.35 |
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. The Company's operations are organized into two business units: (i) Commercial Real Estate Financing, and (ii) Agency Business. Its four reporting segments are as follows: The real estate debt business, The Agency Business, The commercial real estate conduit business, and The real estate owned business.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.